Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:February 24, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Atopic DermatitisLast Updated:February 24, 2021Unknown status
Condition(s):Atopic DermatitisLast Updated:August 12, 2021Terminated
Condition(s):Atopic DermatitisLast Updated:March 8, 2023Completed
Condition(s):Atopic DermatitisLast Updated:June 7, 2022Completed
Condition(s):Seborrheic DermatitisLast Updated:October 29, 2021Completed
Condition(s):HealthyLast Updated:June 24, 2019Completed
Condition(s):Dermatitis, AtopicLast Updated:August 24, 2021Completed
Condition(s):Stasis DermatitisLast Updated:May 2, 2022Completed
Condition(s):Dermatitis, AtopicLast Updated:August 13, 2019Completed
Condition(s):Metastatic Colorectal Cancer; Cetuximab; Skin ToxicityLast Updated:November 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.